Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week
March 11, 2024 at 14:29 PM EDT
The FDA has granted breakthrough designation to Mind Medicine's program for the treatment of generalized anxiety disorder.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
